1. Home
  2. THW vs BWAY Comparison

THW vs BWAY Comparison

Compare THW & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

THW

abrdn World Healthcare Fund Shares of Beneficial Interest

HOLD

Current Price

$13.33

Market Cap

516.7M

Sector

Finance

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$16.52

Market Cap

578.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THW
BWAY
Founded
N/A
2003
Country
United States
Israel
Employees
N/A
129
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
516.7M
578.5M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
THW
BWAY
Price
$13.33
$16.52
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.25
AVG Volume (30 Days)
160.9K
76.6K
Earning Date
01-01-0001
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$309.69
Revenue Next Year
N/A
$26.21
P/E Ratio
N/A
$81.98
Revenue Growth
N/A
N/A
52 Week Low
$10.41
$11.35
52 Week High
$13.79
$26.63

Technical Indicators

Market Signals
Indicator
THW
BWAY
Relative Strength Index (RSI) 54.73 64.14
Support Level $12.33 $14.21
Resistance Level $13.79 $17.82
Average True Range (ATR) 0.23 0.67
MACD -0.04 0.13
Stochastic Oscillator 34.19 87.62

Price Performance

Historical Comparison
THW
BWAY

About THW abrdn World Healthcare Fund Shares of Beneficial Interest

Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: